Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 269 No 7220 p559
19 October 2002

This article
Reprint
Photocopy


News summary

 


Opioids effctive in treatment of post-shingles neuralgia

Opioids can be used to treat postherpetic neuralgia (PHN), according to American researchers.

They found that opioids were as effective as tricyclic antidepressants (TCA) currently used for this indication, and that they did not affect patients’ cognitive function. In a cross-over trial, 76 patients with PHN were randomised to receive opioids, TCA and placebo, during three separate eight-week treatment periods. Mean daily maintenance doses were morphine 91mg or methadone 15mg, and nortriptyline 89mg or desipramine 63mg.

There was no difference between opioids and TCA in terms of pain relief, but both resulted in greater pain relief than placebo (38 and 32 per cent, respectively, versus 11 per cent, P=0.001), with no appreciable effect on any cognitive measure.

However, more patients preferred opioids (54 per cent) than TCA (30 per cent). The researchers say the role of opioids has been controversial but argue that these drugs could be a useful alternative treatment for neuropathic pain (Neurology 2002;59:1015).

 

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal